Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jindie Qingyan (金蝶清咽含片) is a Traditional Chinese Medicine (TCM) product developed by Yunnan Xitao Green Pharmaceutical Co., Ltd. for the treatment of acute pharyngitis. It is specifically formulated as a lozenge or buccal tablet to address the 'lung-stomach excess heat type throat impediment' (肺胃实热型喉痹) syndrome. The medication aims to alleviate symptoms such as throat pain, swelling, and congestion by clearing heat and detoxifying the respiratory tract. Clinical trials in China have evaluated its safety and efficacy compared to standard treatments for acute throat inflammation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jindie Qingyan.